Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dai's Natto is a New York-based functional food company specializing in the production of fresh, artisanal natto, a traditional Japanese fermented soybean dish. Founded by Dai Kong, the company focuses on the health-promoting properties of natto, which is naturally rich in nattokinase, Vitamin K2, and the probiotic bacterium Bacillus subtilis var. natto. The company's mission is to provide high-quality, non-GMO, and preservative-free fermented foods to the American market, positioning its products within the 'food as medicine' category. Natto is recognized for its potential benefits in supporting cardiovascular health, bone density, and digestive wellness. Dai's Natto operates a production facility in Long Island City and distributes its products through specialty retailers, health food stores, and direct-to-consumer channels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dai's Natto.